Services

Medical Consultancy

Medical Writing

Expert Medical Writing Services by a Trusted Medical Writing Consultant

High-quality medical writing is essential for transforming complex scientific data into clear, compliant, and impactful documentation. By working with an experienced medical writing consultant, you ensure that every deliverable — from clinical study reports to regulatory submissions — meets international standards, supports faster approvals, and communicates your data with precision and integrity.

Why choose a medical writing consultant?

Partnering with an experienced medical writing consultant ensures that your documentation is scientifically sound, regulatory-compliant, and aligned with industry expectations. Whether you need clinical study reports, regulatory submissions, or peer-reviewed publications, our team guarantees clarity, accuracy, and strategic alignment across all your deliverables.

A seasoned medical writing consultant brings not only writing expertise but also deep therapeutic area knowledge and a clear understanding of regulatory landscapes across global markets. This expertise minimizes the risk of delays, improves the quality of your submissions, and enhances communication with regulatory authorities and stakeholders. With our support, your data tells a compelling story — clearly, consistently, and with scientific integrity.

Choosing the right medical writing consultant can be the key to delivering documentation that is not only compliant, but also clear, persuasive, and scientifically robust. At Billev Pharma East, our consultants combine regulatory insight with medical expertise to support your success — from early-phase development to final submission, ensuring every document is tailored, reviewer-friendly, and aligned with current guidelines and expectations across global regulatory environments.

In today’s fast-paced and highly regulated life sciences sector, high-quality medical writing can accelerate approvals, build credibility with stakeholders, and streamline communication with regulatory bodies. Our consultants work closely with your internal teams, offering flexible collaboration models and a deep understanding of both clinical and non-clinical documentation needs. With Billev Pharma East, you gain a reliable partner committed to transforming complex scientific data into clear, impactful content that meets the highest industry standards.

How to Reach us?

Billev farmacija vzhod, d. o. o.
Billev Pharma East Ltd.
Tržaška cesta 202

1000 Ljubljana

Slovenia

Partnering with a medical writing consultant enables you to:

  • Streamline communication with regulators and partners.

  • Reduce review cycles and submission delays.

  • Focus your internal resources on core development activities.

  • Meet EMA, FDA, and ICH documentation standards.

Events

  • 4 – 8 October 2025 – Barcelona (Spain): Our colleague Jana Brajdih Čendak took part in the EANM 2025 Annual Congress in Barcelona, where leading experts in nuclear medicine and molecular imaging gathered to share the latest advances in theranostics, imaging technologies and patient-centric regulatory trends. She also met with our key business partners to strengthen collaboration and align on upcoming initiatives.
Medical writing of regulatory documentation:
  • Clinical Overview and Summary (all legal basis applications)
  • Non-clinical Overview and Summary (all legal basis applications)
  • Clinical Study Reports (CSRs), protocols, Investigators brochures (IBs), safety narratives
  • Environmental Risk Assessment
  • SmPC, PIL
  • Bridging reports (readability)
  • Writing of medical / pharmaceutical publications for journals
Medical writing in Pharmacovigilance:
  • Company Core Data Sheet, Company Core Safety Information
  • Periodic Safety Update Reports (PSUR / PBRER)
  • Risk-benefit reports
  • Signal detection
  • Risk Management Plan (RMP)
  • Medical assessment of adverse drug reactions
  • Medical Enquiries
Biosimilar medicines:

We offer guidance on comparability testing and preparation of non-clinical and clinical documentation, as required per Article 10(4) of Directive 2001/83/EC for the licensing of biosimilar medicinal products. Our experts can assist you in the registration phase,
as well as in the post-marketing phase by managing the product’s pharmacovigilance.

More ways,
we can help.

With a focus on expert guidance and strategic insights, we propel your projects forward with confidence, ensuring every step is handled with precision.

Don’t miss out
Follow us on LinkedIn
Watch our
promotional video

HOME

SERVICES

Regulatory Affairs

PharmacoVigilance

Medical Consultancy

Quality / GxP

Digital Consultancy

TEAM OF EXPERTS

ABOUT US

NEWS AND EVENTS

B2B PARTNER LOG-IN